The Nov. 16 issue of The Bee carried two articles about very promising medical advances that involve treating severe congenital diseases.
One was about growing replacement heart valves, and the other was about treatment of muscular dystrophy in an experimental model in dogs. In one case, the potential treatment used amniotic fluid cells, and the other involved adult stem cells. Neither involved embryonic stem cells.
Bee readers are thus reminded of what opponents of the California stem cell initiative Proposition 73 said during the election campaign last year. The most promising medical advances are coming from work in adult stem cells, and that is where research money should be spent.
The Proposition 73 boondoggle hasn't gotten out of the station, and even if it does, it is on the wrong track.